Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Ashwini Davison Justin Dunn Jason Mock Deepa Rangachari May 13, 2009.
Myocardial infarction New concepts New definitions.
A.Abdi,M.D. Initial Diagnosis Symptoms ECG Cardiac Biomarkers.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
Myocardial Infarction
Bojana Gardijan 4th year March 16, 2010 Mentor: A. Žmegač Horvat.
Myocardial Ischemia, Injury, and Infarction
Garik Misenar, MD, FACEP.  Understand differential diagnosis of chest pain  Learn key points in the evaluation of chest pain  Know the key findings.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
Approach to Chest Pain. History “When it comes to chest pain, if you aren’t confident with your diagnosis after your history, take it again” Dr. M. Gamble.
ACUTE CORONARY SYNDORME EARLY RISK STRATIFICATION Sarah Jamison March 2003.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Acute Coronary Syndromes
Ischemic Heart Disease (IHD – coronary Heart Disease)
Principles of diagnsosis of ischemic heart disease Mohammad Hashemi Interventional cardiologist Department of cardiology.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Acute coronary syndrome : Pathophysiology.  ACS – is a continuum disease process. Patients with acute coronary syndromes have some degree of coronary.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
1 DIAGNOSTICS OF Acute Coronary Syndromes At the end of this self study the participant will: Verbalize meanings of specific ECG changes: –ST Elevation.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. MYOCARDIAL INFARCTION Prof.
Anything that you want to know about troponins but never ask
Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
Acute Coronary Syndrome
Acute Coronary Syndromes
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
Biochemical Investigations In Heart Disaeses
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention David M. Larson MD, Katie M. Menssen, BS,, Scott W Sharkey.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Antiplatelet Interventions in Acute Coronary Syndromes.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Biochemical Markers of Myocardial Infarction
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Cost Conscious Project: How Many Troponins Does It Take? Rola Khedraki.
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Acute Coronary Syndromes Chapter 12 Cardiovascular Disorders Medical Surgical Nursing II.
Chest Pain in the Emergency Department Junior Teaching C. Brown August 2015.
No conflicts of interest or financial ties to disclose.
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Indication Contraindication Preparation
Acute Coronary Syndrome
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Prehospital NSTEMI Patient Assessment and Treatment
Cardiac causes of cardiac arrest
Risk Stratification of Chest Pain: Best Practices
Biochemical Investigations In Heart Disaeses
Coronary artery disease
CORONARY ARTERY DISEASE
CHEST PAIN.
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Ischemic Heart Disease
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Coronary artery disease
Section A: Introduction
European Heart Association Journal 2007 April
Division of Cardiovascular Diseases No relevant author disclosures
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium

Introduction  ACS in ED is frequent, often difficult to recognize, a major cause of morbidity and mortality with prognosis related to early treatment high risk of suboptimal care with poor outcome high need for management strategy

 ACS classification (focus on ECG and troponin) ST-elevation myocardial infarction (STEMI) non-STEMI (includes "micro-infarctions", i.e. no ECG changes, no CK-MB, only troponin ) unstable angina (no troponin )

New criteria for acute, evolving or recent MI Either one of the following criteria satisfies the diagnosis for an acute, evolving or recent MI : 1. Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Q waves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d)coronary artery intervention (e.g. coronary angioplasty). 2.Pathologic findings of an acute MI

 Illustrative figures (USA) ACS accounts for only 20% among 6 million chest pain patients in ED costs to rule out ACS : 500 to 5,000 S missed ACS diagnosis in ED : 2 to 5%, with 30 day mortality rate of 10% missed MI diagnosis in ED : 40% of mal- practice awards against emergency physicians at least 20% of non-ACS patients with chest pain suffer from (potentially) life threatening diseases : aortic dissection, pulmonary embolism, stable angina, pneumothorax,...

Risk stratification Patient presents with chest pain or potential chest pain equivalent (e.g. jaw, shoulder, arm, back, or epigastric pain, unexplained dyspnea, syncope, palpitations) Chest pain triage and ECG (< 10 min) Physician's historyPhysician's physical examination Prompt 12- or 15-lead ECG Prompt differentiation ST-segment elevation meeting fibrinolytic criteria or new/presumably new LBBB or evidence of acute posterior MI ST-segment depression > 0.5 mm or transient ST-segment elevation not meeting fibrinolytic criteria (ECG or clinical evidence of unstable angina) Very low suspicion of ACS (modified from Pollack et al,2003) ECG is nondiagnostic or normal Clinical suspicion of ACS

 Nature of presenting episode and time course  Cardiac risk factors (previous MI, hypertension, lipids, smoking, diabetes, family history) and related past medical (atherosclerotic cardio- vascular disease, CVA, peripheral vascular disease) and surgical history (percutaneous coronary intervention, CABG)  Comorbidities and quick review of systems (to suggest alternative diagnoses, such as lung infection or infarction, chest wall or gastro-intestinal pain) (Pollack et al,2003) Physician's history

 Evaluate hemodynamic status and perfusion  Lung auscultation for rales, ronchi,...  Evaluate for possible alternative diagnoses (e.g. chest wall pain, pneumonia, pulmonary embolism, [evidence of DVT])  Cardiac examination (Pollack et al,2003) Physician's physical examination

ECG for acute chest pain  Not a perfect diagnostic tool (specificity-sensitivity) 10% of new ST-elevations are not caused by MI Up to 50% of MI patients present with normal or inconclusive ECG (e.g. previous MI, LV hypertrophy) 2% of patients with normal ECG will develop MI  15-lead ECG for right ventricular or posterior MI  Request previous ECG for comparison  Serial ECGs (and continuous ST-monitoring?) improve sensitivity

Risk stratification Patient presents with chest pain or potential chest pain equivalent (e.g. jaw, shoulder, arm, back, or epigastric pain, unexplained dyspnea, syncope, palpitations) Chest pain triage and ECG (< 10 min) Physician's historyPhysician's physical examination Prompt 12- or 15-lead ECG Prompt differentiation ST-segment elevation meeting fibrinolytic criteria or new/presumably new LBBB or evidence of acute posterior MI ST-segment depression > 0.5 mm or transient ST-segment elevation not meeting fibrinolytic criteria (ECG or clinical evidence of unstable angina) Very low suspicion of ACS (modified from Pollack et al,2003) ECG is nondiagnostic or normal Clinical suspicion of ACS Markers and/or ECG to rule out ACS or to guide strategy therapy Markers and ECG to confirm MI and to determine prognosis

The perfect marker  Marker for myocardial necrosis, and also for cardiac ischemia  Linear relationship between blood levels and extent of myocardial injury (and prognosis)  100% sensitive  100% specific  Immediate increase (+ constant blood level for hours to days)  Test kits : reliable, rapid, universally available and inexpensive

What about troponin T and I ?  Very high sensitivity for myocardial necrosis  Related to prognosis  Not 100% specific for atherosclerotic coronary artery disease myocarditis, cardiomyopathy, myocardial contusion,... renal failure, auto-immune diseases,...)  Up to 6 hours before raised blood levels no early MI diagnosis possible  Raised blood levels for many days troublesome diagnosis of re-infarction BUT

Role for myoglobin ?  Initial elevation : 1 to 4h after onset better early marker than troponins BUT : early myoglobin is less sensitive and less specific (due to skeletal muscle trauma) than late troponin decisions mainly based on clinical skills, ECG and late troponin (except rarely for reperfusion therapy)  Duration of elevation : 24 – 48h useful for re-infarction diagnosis

Role for CK-MB ?  Initial elevation comparable with troponins  Less sensitive than troponins  High specificity (comparable with troponins)  Rapid rise and fall (instead of gradual fall for troponins) allowing more accurate estimation of MI extent

ED strategy in chest pain patients Patient presents with chest pain or potential chest pain equivalent (e.g. jaw, shoulder, arm, back, or epigastric pain, unexplained dyspnea, syncope, palpitations) Chest pain triage and ECG (< 10 min) Physician's historyPhysician's physical examination Prompt 12- or 15-lead ECG Prompt differentiation STEMI Non-STEMI unstable angina Other causes of chest pain (modified from Pollack et al,2003) Start appropriate treatment and send patient to CCU or cath lab Suspicion of ACS Continuous risk- oriented ACS evaluation and treatment in ED Diagnostic workup and treatment as indicated in ICU, ward, ED or as outpatient

TIMI risk score 1 point each for presence of :  Age > 65 years  Documented prior coronary artery stenosis > 50%  Three or more conventional cardiac risk factors (e.g. age, sex, family history, hyperlipidemia, diabetes, smoking, obesity)  Use of aspirin in the preceding 7 days  Two or more anginal events in the preceding 24h  ST-segment deviation (transient elevation or persistent depression)  Increased cardiac biomarkers Score 5 – 7 : high risk Score 3 – 4 : intermediate risk Score 0 – 2 : low risk (Pollack et al, 2003)

Conclusions  The diagnosis of ACS during the first few hours of evolution is a difficult task that challenges the best of (emergency) physicians.  Critical decisions should be based on much more elements than biomarkers.  For emergency physicians, the most difficult and medicolegally risky decisions center on how to minimize the costs to the healthcare system without jeopardizing the quality of care provided to patients with atypical symptoms and/or inconclusive ECG. Chest pain center